Kelly_Stratton

Kelly L. Stratton MD

OU Health Stephenson Cancer Center

Kelly L. Stratton, MD, is an Assistant Professor of Urologic Oncology and Director of Research in the Department of Urology at the OU Health Stephenson Cancer Center. He also holds a faculty appointment at the University of Oklahoma as Adjunct Assistant Professor of Medical Oncology.

Dr. Stratton received his medical degree with special distinction at OU College of Medicine. He completed his residency at Vanderbilt University Medical Center Department of Urology and later a fellowship in the Department of Surgery at Memorial Sloan Kettering Cancer Center.

Dr. Stratton is experienced in state-of-the-art imaging for the diagnosis and treatment of prostate cancer. His clinical interests focus on the application of new technology capable of blending MRI images with real-time ultrasound to improve prostate biopsy and cancer detection. Using these techniques, he supports the decision-making process for patients who are considering prostate cancer treatment options, including those who are candidates for active surveillance. He also utilizes genomic testing to help provide personalized treatment plans for patients diagnosed with urologic cancer.

In addition to his other roles, Dr. Stratton is the Clinic Director of the Prostate and Urologic Cancer Clinic and the Chair of the Stephenson Cancer Center Data Safety Monitoring Board Disease Site Chair for Urologic Cancer. He also is a member of the Oklahoma TSET Phase I Clinical Trials Program.

Dr. Stratton holds memberships with several professional organizations, including the American Society of Clinical Oncology, the Society of Urologic Oncology, and the American Urological Association. He serves as a reviewer for the Journal of Radiology and was recently awarded the Best Reviewer in Oncology. He also is a contributor to Practical Reviews in Urology with an emphasis on urologic oncology. Dr. Stratton has authored numerous publications and abstracts, as well as a book chapter for the American Cancer Society regarding inherited predisposition to cancer.


Appearances